146 related articles for article (PubMed ID: 2056773)
21. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
[TBL] [Abstract][Full Text] [Related]
22. Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis.
Wright DG; Boosalis MS; Waraska K; Oshry LJ; Weintraub LR; Vosburgh E
Anticancer Res; 1996; 16(6A):3349-51. PubMed ID: 9042310
[TBL] [Abstract][Full Text] [Related]
23. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
24. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Kuyama J; Take H
Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
[TBL] [Abstract][Full Text] [Related]
25. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.
Campiotti L; Grandi AM; Biotti MG; Ultori C; Solbiati F; Codari R; Venco A
Am J Hematol; 2007 Mar; 82(3):231-3. PubMed ID: 17022045
[TBL] [Abstract][Full Text] [Related]
26. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.
Kantarjian HM; Beran M; O'Brien S; Robertson L; Siddik Z; Yoshida M; Yang LY; Rios MB; Keating MJ; Meyer M
Leukemia; 1996 Mar; 10(3):396-401. PubMed ID: 8642853
[TBL] [Abstract][Full Text] [Related]
28. The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia.
Wakim JJ; Tirado CA; Dowell J; Chen W
Cancer Genet; 2012 Mar; 205(3):124-7. PubMed ID: 22469511
[TBL] [Abstract][Full Text] [Related]
29. Isolated central nervous system blast crisis in chronic myeloid leukemia.
Rajappa S; Uppin SG; Raghunadharao D; Rao IS; Surath A
Hematol Oncol; 2004 Dec; 22(4):179-81. PubMed ID: 15995975
[TBL] [Abstract][Full Text] [Related]
30. Chronic granulocytic leukemia in blastic crisis. Prognostic factors.
Sales V; Rojo J; Collazo J; Lagunas E; Aguilar E; Albisua L
In Vivo; 1991; 5(3):281-5. PubMed ID: 1893082
[TBL] [Abstract][Full Text] [Related]
31. Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies.
Petti MC; Fazi F; Gentile M; Diverio D; De Fabritiis P; De Propris MS; Fiorini R; Spiriti MA; Padula F; Pelicci PG; Nervi C; Lo Coco F
Blood; 2002 Aug; 100(3):1065-7. PubMed ID: 12130525
[TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of acute promyelocytic leukemia with trans-retinoic acid. Experience of the Santa Maria Hospital, Medical School of Lisbon].
De Lacerda JF; Do Carmo JA; De Moura MC; Guerra ML; Lopes C; Raposo J; Melo A; De Oliveira JJ; De Lacerda JM
Acta Med Port; 1994 Dec; 7(12):717-24. PubMed ID: 7717119
[TBL] [Abstract][Full Text] [Related]
34. [Ph1-positive chronic myelocytic leukemia developing promyelocytic acute crisis with addition of isochromosome (17q), report of two cases].
Shibata K; Uike N; Takeichi N; Akiyoshi T; Takahira H; Kozuru M
Rinsho Ketsueki; 1988 Dec; 29(12):2335-42. PubMed ID: 3246719
[No Abstract] [Full Text] [Related]
35. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
Castaigne S; Degos L
C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
[TBL] [Abstract][Full Text] [Related]
37. Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis: report of two cases with molecular studies.
Cervantes F; Urbano-Ispizua A; Villamor N; Feliu E; Milla F; Lopez-Guillermo A; Ribera JM; Granada I; Vives-Corrons JL; Montserrat E
Leukemia; 1993 Feb; 7(2):327-30. PubMed ID: 8426485
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
[TBL] [Abstract][Full Text] [Related]
39. Promyelocytic blast crisis of chronic myelogenous leukemia. A rare subtype associated with disseminated intravascular coagulation.
Rosenthal NS; Knapp D; Farhi DC
Am J Clin Pathol; 1995 Feb; 103(2):185-8. PubMed ID: 7856560
[TBL] [Abstract][Full Text] [Related]
40. Development of acute promyelocytic leukemia with isochromosome 17q after BCR/ABL positive chronic myeloid leukemia.
Oren H; Düzovali O; Yüksel E; Sakizli M; Irken G
Cancer Genet Cytogenet; 1999 Mar; 109(2):141-3. PubMed ID: 10087949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
